Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
We compare Dividend Growth ETFs to reveal the one with the lowest expense ratio, helping you maximize net returns without sacrificing growth.
28,176 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A May 2026 poll defines a new voter cohort—the disillusioned—showing widespread financial strain and a belief that th...
Bitcoin Suisse (Europe) AG has earned a MiCAR-based Crypto Asset Service Provider license, prompting a Europe-wide ex...
Microsoft is reshaping its Xbox division with sweeping layoffs exceeding 3,000 workers, signaling a hard reset that c...
Thursday brought a lift to D-Wave stock as a quarterly momentum signal emerged. This guide breaks down the catalysts ...
As AI compute demand climbs, investors wonder if nebius group stock still holds appeal after Meta's AI cloud move. Th...
SoundHound AI faced a sharp stock move after a major leadership change. This article breaks down what happened, why i...
Analysts are arguing that Merck's sac-TMT program could unlock substantial upside for MRK, supported by a strong pipe...
A new Fed chair angles for a disciplined inflation fight and a leaner balance sheet, even as markets seek clarity. He...
Investors weigh growth plans and political headlines as DJT faces a volatile path to profitability, with forecasts sp...
July 16 could be a pivotal date for Nvidia and the broader AI chip ecosystem. This guide explains why Nvidia investor...
NVIDIA stock is under pressure as a wave of AI infrastructure spending by the Magnificent Seven tests profits versus ...